Insulin cardioplegia for elective coronary bypass surgery

Slides:



Advertisements
Similar presentations
The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications Jih-Shiuan Wang, MD, Dominique.
Advertisements

Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Bidirectional cavopulmonary shunt with right ventricular outflow patency: The impact of pulsatility on pulmonary endothelial function  Shunji Kurotobi,
Predictors of low cardiac output syndrome after coronary artery bypass
Early reperfusion with warm, polarizing adenosine–lidocaine cardioplegia improves functional recovery after 6 hours of cold static storage  Donna M. Rudd,
Revascularization of severe hibernating myocardium in the beating heart: early hemodynamic and metabolic features  Evasio Pasini, MD, Gianna Ferrari,
Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial.
Vitamin E for coronary bypass operations
Minimizing intraoperative hemodilution by use of a very low priming volume cardiopulmonary bypass in neonates with transposition of the great arteries 
Delivery of a nonpotassium modified maintenance solution to enhance myocardial protection in stressed neonatal hearts: A new approach  Michael T. Kronon,
Assessment of Continuous Cold Blood Cardioplegia in Coronary Artery Bypass Grafting  Yves A.G Louagie, Emmanuel Gonzalez, Jacques Jamart, Brigitte Malhomme,
Optimal flow rates for integrated cardioplegia
Walter J. Scott, M.D., Bruce L. Gewertz, M.D. 
Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss  Gideon Cohen, Joan Ivanov, Richard D Weisel, Vivek Rao, Molly K Mohabeer,
Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation  Paul W.M. Fedak, MD, PhD, Vivek Rao,
Penehyclidine hydrochloride preserves the intestinal barrier function in patients undergoing cardiopulmonary bypass  Ying-jie Sun, PhD, Dan-dan Song,
Improved myocardial protection with blood and crystalloid cardioplegia
Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction  Katsuhiko Nakanishi, MD,
Steven R. Gundry, MD, Matthew A. Romano, MD, O
Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting  Harold L. Lazar, MDa, George Philippides, MDb, Carmel.
Multilevel data analysis: What? Why? How?
Harold L. Lazar, MD  The Journal of Thoracic and Cardiovascular Surgery 
Long-term results of simultaneous carotid endarterectomy and myocardial revascularization with cardiopulmonary bypass used for both procedures  Kazutomo.
Antegrade and retrograde cardioplegia: Alternate or simultaneous?
Intraoperative myocardial protection: current trends and future perspectives  Gideon Cohen, MD, Michael A Borger, MD, Richard D Weisel, MD, Vivek Rao,
Normokalemic adenosine–lidocaine cardioplegia: Importance of maintaining a polarized myocardium for optimal arrest and reanimation  Kathryn L. Sloots,
Effect of acutely increased left ventricular afterload on work output from the right ventricle in conscious dogs  Mohanraj K. Karunanithi, BE, MBiomedE,
Oxygen consumption after cardiopulmonary bypass surgery in children: Determinants and implications  Jia Li, MDa, Ingram Schulze-Neick, MDa, Christopher.
Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): Is it preconditioning? 
George T. Christakis, M. D. , Stephen E. Fremes, M. D. , Richard D
Nitecapone as an additive to crystalloid cardioplegia in patients who had coronary artery bypass grafting  Antti E Vento, MD, Juha Aittomäki, MD, Kalervo.
Free radical reaction products and antioxidant capacity in arterial plasma during coronary artery bypass grafting  Hannu J. Toivonen, MD, PhDa, Markku.
Continuous cold blood cardioplegia improves myocardial protection: a prospective randomized study  Yves A.G Louagie, MD, PhD, Jacques Jamart, MD, Manuel.
Endothelin-1 during and after cardiopulmonary bypass: Association to graft sensitivity and postoperative recovery  Brian R. Bond, PhD, B.Hugh Dorman,
Protecting the aged heart during cardiac surgery: Use of del Nido cardioplegia provides superior functional recovery in isolated hearts  Arun Govindapillai,
Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia  Stacy B. O’Blenes, MD, Camille Hancock Friesen, MD,
Aortic coarctation in the adult: Management of complications and coexisting arterial abnormalities with hypothermic cardiopulmonary bypass and circulatory.
Experimental study of intermittent crossclamping with fibrillation and myocardial protection: Reduced injury from shorter cumulative ischemia or intrinsic.
Effect of hemoglobin concentration on oxyhemoglobin dissociation during hypothermic blood cardioplegic arrest  William L. Holman, MD, Walter V.A. Vicente,
Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass  Benjamin Medalion, MD, Michael G. Katz, MD,
Ischemic postconditioning promotes left ventricular functional recovery after cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion.
S. Martens, MD, M. Dietrich, MD, M. Doss, MD, G
Leora B. Balsam, MD, Abe DeAnda, MD 
Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD 
The Ross procedure: Time to reevaluate the guidelines
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery  Vivek Rao, MD, PhD, Joan Ivanov, RN, MSc, Richard.
Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia  Vivek Rao, MD, PhD, Frank Merante, PhD,
Beneficial effects of ischemic preconditioning on right ventricular function after coronary artery bypass grafting  Zhong-Kai Wu, MD, Matti R Tarkka,
Deep hypothermic circulatory arrest during the arterial switch operation is associated with reduction in cerebral oxygen extraction but no increase in.
Shunt right or left? Decision 2016
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass  Sudip Ghosh, MD, Manuel Galiñanes,
Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: Reversal by means.
Spencer W. Galt, MD, Fritz R. Bech, MD, Martha D
Tai Ji: The law of inflammatory response
The future of cardiac surgery training: A survival guide
Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis  Michael A Borger, MD, Stephen E Fremes, MD, Richard.
Novel cerebral physiologic monitoring to guide low-flow cerebral perfusion during neonatal aortic arch reconstruction  Dean B. Andropoulos, MDa, Stephen.
Neuropsychologic impairment after coronary bypass surgery: Effect of gaseous microemboli during perfusionist interventions  Michael A. Borger, MD, Charles.
Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery†  L. Tritapepe, V. De Santis, D. Vitale, F. Guarracino,
Managing conflicts of interest
Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery  Yoshiya Toyoda, MD, Masahiro Yamaguchi,
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions  Ruth L Taylor, MSc, Michael A Borger, MD, Richard.
Captopril in Cardioplegia and Reperfusion: Protective Effects on the Ischemic Heart  Jacob Gurevitch, Dimitri Pevni, Inna Frolkis, Menachem Matsa, Yosi.
Reduced Cytokines Release and Myocardial Damage in Coronary Artery Bypass Patients Due to L-Arginine Cardioplegia Supplementation  Luisa Colagrande, MD,
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study  Michael A Borger, MD, Kevin S Wei, MD, Richard D Weisel,
Comparing microvascular alterations during minimal extracorporeal circulation and conventional cardiopulmonary bypass in coronary artery bypass graft.
Journal changes and initiatives
Acquired aortopulmonary fistula in acute dissection
Y.John Gu, MD, PhD, Piet W. Boonstra, MD, PhD, Willem van Oeveren, PhD 
Presentation transcript:

Insulin cardioplegia for elective coronary bypass surgery Vivek Rao, MD, PhD, Michael A. Borger, MD, Richard D. Weisel, MD, Joan Ivanov, RN, George T. Christakis, MD, Gideon Cohen, MD, Terrence M. Yau, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 119, Issue 6, Pages 1176-1184 (June 2000) DOI: 10.1067/mtc.2000.105257 Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 1 Arterial glucose concentrations in all 4 study groups. The differences in arterial glucose observed during cardioplegic arrest dissipated within 2 hours of arrival into the ICU. There were no overall differences in arterial glucose concentrations between groups. PRE , Prebypass; Xcl , aortic occlusion; Xcl OFF , removal of crossclamp; CPB 10 ’, 10 minutes after discontinuation of cardiopulmonary bypass; 5’, 10’, 2 HR, 4 HR, 8 HR, 24 HR , time after crossclamp removal. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1176-1184DOI: (10.1067/mtc.2000.105257) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 2 Intraoperative myocardial lactate flux. Cardioplegic arrest induced significant anaerobic lactate release in all patients. Over time, there were no significant effects of either glucose concentration (upper panel, P = .83) or insulin (lower panel , P = .28) on myocardial lactate flux. However, immediately after crossclamp removal, patients who received insulin cardioplegia demonstrated lactate extraction compared with persistent anaerobic lactate release in the placebo groups (P = .03 by using the Student t test). PRE , Prebypass; XCL , aortic occlusion; OFF , removal of crossclamp; LAST, final cardioplegic dose. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1176-1184DOI: (10.1067/mtc.2000.105257) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 3 Effects of glucose (upper panel) and insulin (lower panel) on intraoperative myocardial oxygen extraction. During the crossclamp period, there was a significant interactive effect between glucose and insulin (P = .03). During reperfusion, myocardial oxygen extraction returned to baseline in the insulin cardioplegia groups. However, there was increased oxygen extraction in the placebo groups, suggestive of repayment of an oxygen debt. There was no significant effect of glucose concentration (P = .33); however, there was a significant insulin effect over time (insulin·time effect, P = .04). PRE , Prebypass; XCL , aortic occlusion; OFF , removal of crossclamp; LAST, final cardioplegic dose. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1176-1184DOI: (10.1067/mtc.2000.105257) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 4 Myocardial PDH activity (nanomoles per milligrams per minute) before cardioplegic arrest (PRE) , just before aortic crossclamp removal (XCL) , and after 10 minutes of reperfusion (OFF) . PDH activity increased during cardioplegic arrest but returned to baseline values during early reperfusion (time effect, P = .009). There were no significant effects of either glucose or insulin on PDH activity (group effect, P = .48). The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1176-1184DOI: (10.1067/mtc.2000.105257) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions

Fig. 5 Cardiac index (upper panel) and left ventricular stroke work index (lower panel) at 2 hours after surgery. Patients who received insulin cardioplegia demonstrated enhanced left ventricular performance compared with placebo at similar filling pressures. PCWP , Pulmonary capillary wedge pressure. Circles represent low-glucose cardioplegia, squares represent high-glucose cardioplegia, open symbols represent placebo groups, and closed symbols represent insulin groups. The Journal of Thoracic and Cardiovascular Surgery 2000 119, 1176-1184DOI: (10.1067/mtc.2000.105257) Copyright © 2000 American Association for Thoracic Surgery Terms and Conditions